358 related articles for article (PubMed ID: 33861526)
1. Podocyte Sphingolipid Signaling in Nephrotic Syndrome.
Li G; Kidd J; Gehr TWB; Li PL
Cell Physiol Biochem; 2021 Apr; 55(S4):13-34. PubMed ID: 33861526
[TBL] [Abstract][Full Text] [Related]
2. Podocytopathy and Nephrotic Syndrome in Mice with Podocyte-Specific Deletion of the Asah1 Gene: Role of Ceramide Accumulation in Glomeruli.
Li G; Kidd J; Kaspar C; Dempsey S; Bhat OM; Camus S; Ritter JK; Gehr TWB; Gulbins E; Li PL
Am J Pathol; 2020 Jun; 190(6):1211-1223. PubMed ID: 32194052
[TBL] [Abstract][Full Text] [Related]
3. Sphingomyelin Phosphodiesterase Acid-Like 3b is Essential for Toll-Like Receptor 3 Signaling in Human Podocytes.
Watanabe S; Hidenori U; Hashimoto S; Riko S; Aizawa T; Tsugawa K; Imaizumi T; Tanaka H
J Membr Biol; 2022 Feb; 255(1):117-122. PubMed ID: 34739556
[TBL] [Abstract][Full Text] [Related]
4. The impact of steroids on the injured podocytes in nephrotic syndrome.
Hosseiniyan Khatibi SM; Ardalan M; Abediazar S; Zununi Vahed S
J Steroid Biochem Mol Biol; 2020 Feb; 196():105490. PubMed ID: 31586640
[TBL] [Abstract][Full Text] [Related]
5. Translating genetic findings in hereditary nephrotic syndrome: the missing loops.
Hall G; Gbadegesin RA
Am J Physiol Renal Physiol; 2015 Jul; 309(1):F24-8. PubMed ID: 25810439
[TBL] [Abstract][Full Text] [Related]
6. Abnormal podocyte TRPML1 channel activity and exosome release in mice with podocyte-specific Asah1 gene deletion.
Li G; Huang D; Bhat OM; Poklis JL; Zhang A; Zou Y; Kidd J; Gehr TWB; Li PL
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Feb; 1866(2):158856. PubMed ID: 33221496
[TBL] [Abstract][Full Text] [Related]
7. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
8. Discovery of endoplasmic reticulum calcium stabilizers to rescue ER-stressed podocytes in nephrotic syndrome.
Park SJ; Kim Y; Yang SM; Henderson MJ; Yang W; Lindahl M; Urano F; Chen YM
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14154-14163. PubMed ID: 31235574
[TBL] [Abstract][Full Text] [Related]
9. Podocyte Lysosome Dysfunction in Chronic Glomerular Diseases.
Li G; Kidd J; Li PL
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106480
[TBL] [Abstract][Full Text] [Related]
10. The glomerular permeability factors in idiopathic nephrotic syndrome.
Davin JC
Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
[TBL] [Abstract][Full Text] [Related]
11. Hsp90 inhibition aggravates adriamycin-induced podocyte injury through intrinsic apoptosis pathway.
Dong J; Jiang Z; Ma G
Exp Cell Res; 2020 May; 390(2):111928. PubMed ID: 32156599
[TBL] [Abstract][Full Text] [Related]
12. Human pluripotent stem cell-derived kidney organoids for personalized congenital and idiopathic nephrotic syndrome modeling.
Jansen J; van den Berge BT; van den Broek M; Maas RJ; Daviran D; Willemsen B; Roverts R; van der Kruit M; Kuppe C; Reimer KC; Di Giovanni G; Mooren F; Nlandu Q; Mudde H; Wetzels R; den Braanker D; Parr N; Nagai JS; Drenic V; Costa IG; Steenbergen E; Nijenhuis T; Dijkman H; Endlich N; van de Kar NCAJ; Schneider RK; Wetzels JFM; Akiva A; van der Vlag J; Kramann R; Schreuder MF; Smeets B
Development; 2022 May; 149(9):. PubMed ID: 35417019
[TBL] [Abstract][Full Text] [Related]
13. Translational Aspects of Sphingolipid Metabolism in Renal Disorders.
Abou Daher A; El Jalkh T; Eid AA; Fornoni A; Marples B; Zeidan YH
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186855
[TBL] [Abstract][Full Text] [Related]
14. Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis.
Nawata A; Hisano S; Shimajiri S; Wang KY; Tanaka Y; Nakayama T
Histopathology; 2018 Jun; 72(7):1084-1092. PubMed ID: 29247494
[TBL] [Abstract][Full Text] [Related]
15. Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.
Akchurin O; Reidy KJ
Pediatr Nephrol; 2015 Feb; 30(2):221-33. PubMed ID: 24584664
[TBL] [Abstract][Full Text] [Related]
16. Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome.
Watanabe S; Hirono K; Aizawa T; Tsugawa K; Joh K; Imaizumi T; Tanaka H
Clin Exp Nephrol; 2021 Jan; 25(1):44-51. PubMed ID: 32946006
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of nephrotic syndrome: immuno- or rather podocyte therapy?].
Lewko B
Postepy Hig Med Dosw (Online); 2016 May; 70():459-70. PubMed ID: 27180964
[TBL] [Abstract][Full Text] [Related]
18. Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.
Fujino T; Hasebe N
BMC Nephrol; 2016 Nov; 17(1):179. PubMed ID: 27855638
[TBL] [Abstract][Full Text] [Related]
19. Circulating extracellular vesicles of patients with steroid-sensitive nephrotic syndrome have higher RAC1 and induce recapitulation of nephrotic syndrome phenotype in podocytes.
Eroglu FK; Yazar V; Guler U; Yıldırım M; Yildirim T; Gungor T; Celikkaya E; Karakaya D; Turay N; Ciftci Dede E; Korkusuz P; Salih B; Bulbul M; Gursel I
Am J Physiol Renal Physiol; 2021 Nov; 321(5):F659-F673. PubMed ID: 34569252
[TBL] [Abstract][Full Text] [Related]
20. Recent progress in the pathogenesis of nephrotic proteinuria.
Tesar V; Zima T
Crit Rev Clin Lab Sci; 2008; 45(2):139-220. PubMed ID: 18415815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
